Keensight-backed Symeres acquires Oncolines
The acquisition complements Symeres’ drug discovery capabilities with biology and biophysics capabilities in oncology.
10 January 2023•1 min read
The acquisition complements Symeres’ drug discovery capabilities with biology and biophysics capabilities in oncology.
Eurazeo’s Christophe Bavière: Diversifying Europe’s mid-market
1 hour ago · 7 mins read
Main Capital Partners’ Ferranti agrees to acquire Belgian energy software firm Cogenius
2 hours ago · 2 mins read
Leon Capital backs data center infra biz VKE in ‘highly dynamic’ sector
4 hours ago · 2 mins read
Bertram Capital buys industrial distributor Motion & Control Enterprises from Frontenac
17 hours ago · 2 mins read
Peak Rock’s California Custom Fruits & Flavors buys Skjodt-Barrett nutritional ingredients unit
18 hours ago · 1 min read
Mainsail-backed ChiroHD buys chiropractic billing firm ChiroBilling in add-on deal
19 hours ago · 1 min read
Bain Capital to stay on as HealthSpan agrees $5.7bn Surgery Partners take-private
22 hours ago · 2 mins read
